We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
Cap. Flow
+$169M
Cap. Flow %
0.95%
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160

Top Buys

Rank Stock Value
1
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$41.2M
2
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$30.6M
3
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$29.6M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$28.3M
5
VUSB icon
Vanguard Ultra-Short Bond ETF
VUSB
+$26.7M

Top Sells

Rank Stock Value
1
IJS icon
iShares S&P Small-Cap 600 Value ETF
IJS
+$46M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$45.2M
3
IJJ icon
iShares S&P Mid-Cap 400 Value ETF
IJJ
+$41.1M
4
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$28.8M
5
GLD icon
SPDR Gold Trust
GLD
+$28.6M

Sector Composition

Rank Sector Weight
1 Technology 8.86%
2 Financials 4.76%
3 Consumer Discretionary 4.5%
4 Healthcare 4.18%
5 Consumer Staples 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHY
2901
Credit Suisse High Yield Credit Fund
DHY
$239M
$73K ﹤0.01%
41,434
-15,300
-27% -$29.6K
DOLE icon
2902
Dole
DOLE
$1.23B
$73K ﹤0.01%
10,000
– –
EQX icon
2903
Equinox Gold
EQX
$13.5B
$73K ﹤0.01%
20,040
-42,351
-68% -$165K
MUX icon
2904
McEwen Inc
MUX
$1.18B
$73K ﹤0.01%
22,453
+7,965
+55% +$27.5K
CLVS
2905
DELISTED
Clovis Oncology, Inc.
CLVS
$73K ﹤0.01%
61,667
+10,565
+21% +$16.5K
SOHO
2906
DELISTED
Sotherly Hotels
SOHO
$72K ﹤0.01%
38,318
-3,000
-7% -$6.68K
PRVB
2907
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$72K ﹤0.01%
15,995
– –
CMCT
2908
Creative Media & Community Trust
CMCT
$13.7M
– –
0
– –
DOUG icon
2909
Douglas Elliman
DOUG
$184M
$70K ﹤0.01%
17,969
-3,655
-17% -$18.1K
INO icon
2910
Inovio Pharmaceuticals
INO
$79.6M
$69K ﹤0.01%
3,315
+75
+2% +$1.92K
XXII
2911
22nd Century Group
XXII
$1.49M
– –
0
– –
CTXR icon
2912
Citius Pharmaceuticals
CTXR
$21M
$66K ﹤0.01%
2,184
– –
KODK icon
2913
Kodak
KODK
$992M
$64K ﹤0.01%
14,016
+569
+4% +$3.11K
PSFE icon
2914
Paysafe
PSFE
$352M
$64K ﹤0.01%
3,870
+1,954
+102% +$43.7K
ANNX icon
2915
Annexon
ANNX
$873M
$62K ﹤0.01%
10,000
– –
MIN
2916
Aberdeen Intermediate Income Fund
MIN
$281M
$62K ﹤0.01%
21,924
-281
-1% -$821
WATT icon
2917
Energous
WATT
$93.4M
$62K ﹤0.01%
100
– –
AMBP icon
2918
Ardagh Metal Packaging
AMBP
$3.02B
$61K ﹤0.01%
12,564
-30
-0.2% -$183
ACB
2919
Aurora Cannabis
ACB
$237M
$60K ﹤0.01%
4,877
-200
-4% -$2.94K
MNTS icon
2920
Momentus
MNTS
$91.5M
$60K ﹤0.01%
4
– –
RDW icon
2921
Redwire
RDW
$3.37B
$60K ﹤0.01%
25,351
– –
AKTS
2922
DELISTED
Akoustis Technologies Inc
AKTS
$60K ﹤0.01%
20,066
+848
+4% +$3.44K
ATER icon
2923
Aterian
ATER
$5.09M
$59K ﹤0.01%
3,980
-34
-0.8% -$990
TUEM
2924
DELISTED
Tuesday Morning Corp
TUEM
$58K ﹤0.01%
16,057
+3,650
+29% +$30.2K
CARM
2925
DELISTED
Carisma Therapeutics
CARM
$57K ﹤0.01%
6,746
– –
115 116
117
118 119

Similar funds

TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return

Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
  • Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
  • Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
  • Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.